Novartis
NVS
NVS
1,571 hedge funds and large institutions have $22B invested in Novartis in 2026 Q1 according to their latest regulatory filings, with 197 funds opening new positions, 527 increasing their positions, 535 reducing their positions, and 87 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
0.49% more ownership
Funds ownership: 6.33% → 6.82% (+0.49%)
1% less repeat investments, than reductions
Existing positions increased: 527 | Existing positions reduced: 535
53% less call options, than puts
Call options by funds: $320M | Put options by funds: $681M
Holders
1,571
Holding in Top 10
17
Calls
$320M
Puts
$681M
Top Buyers
| 1 | +$984M | |
| 2 | +$579M | |
| 3 | +$249M | |
| 4 |
WCM Investment Management
Laguna Beach,
California
|
+$224M |
| 5 |
Natixis Advisors
Boston,
Massachusetts
|
+$214M |
Top Sellers
| 1 | -$314M | |
| 2 | -$164M | |
| 3 | -$111M | |
| 4 |
GQG Partners
Ft. Lauderdale,
Florida
|
-$109M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$104M |